La bourse est fermée

Becton, Dickinson and Company (BDX)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
253,15-0,67 (-0,26 %)
À partir de 2:20PM EDT. Marché ouvert.

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
http://www.bd.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein72 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Thomas E. Polen Jr.Pres, CEO & Chairman2,11M1,72M1973
Mr. Christopher R. ReidyChief Admin. Officer1,4MS.O.1957
Mr. Samrat S. KhichiExec. VP of Regulatory & Gov. Affairs and Gen. Counsel2,19MS.O.1967
Mr. Alberto MasExec. VP & Pres of the Medical Segment1,15M1,64M1961
Mr. Christopher DelOreficeExec. VP & CFOS.O.S.O.1971
Mr. Thomas J. SpoerelVP, Controller & Chief Accounting OfficerS.O.S.O.1978
Ms. Elizabeth McCombsExec. VP & Chief Technology OfficerS.O.S.O.1976
Jerry FlaszExec. VP of Global Services & Chief Information OfficerS.O.S.O.S.O.
Ms. Kristen Marie Stewart C.F.A., CFASr. VP of Strategy & Investor RelationsS.O.S.O.S.O.
Michelle QuinnSr. VP and Chief Ethics & Compliance OfficerS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2020 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Becton, Dickinson and Company en date du 1 juillet 2021 est 9. Les scores principaux sont Audit : 6; Société : 7; Droits des actionnaires : 10; Compensation : 8.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.